Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive
1112.2500 -11.45 (-1.02%)
NSE Apr 10, 2026 12:17 PM
Volume: 360.7K
 

logo
Natco Pharma Ltd.
19 Mar 2025
1112.25
-1.02%
buy
by Geojit BNP Paribas
Target: 887
Geojit BNP Paribas
 
Number of FII/FPI investors increased from 254 to 285 in Mar 2026 qtr.
More from Natco Pharma Ltd.
Recommended
Market trades higher, Prestige Estates forms a JV to develop a Rs 9,000 crore project
Trendlyne Marketwatch | 10 Apr 2026, 12:01PM
After the drop, are stock market valuations finally reasonable?
The Baseline | 09 Apr 2026, 03:18PM
Earnings Call Transcript - Q4FY20 for Natco Pharma
| 18 Jun 2020